Literature DB >> 23913813

MLL2 and KDM6A mutations in patients with Kabuki syndrome.

Noriko Miyake1, Eriko Koshimizu, Nobuhiko Okamoto, Seiji Mizuno, Tsutomu Ogata, Toshiro Nagai, Tomoki Kosho, Hirofumi Ohashi, Mitsuhiro Kato, Goro Sasaki, Hiroyo Mabe, Yoriko Watanabe, Makoto Yoshino, Toyojiro Matsuishi, Jun-ichi Takanashi, Vorasuk Shotelersuk, Mustafa Tekin, Nobuhiko Ochi, Masaya Kubota, Naoko Ito, Kenji Ihara, Toshiro Hara, Hidefumi Tonoki, Tohru Ohta, Kayoko Saito, Mari Matsuo, Mari Urano, Takashi Enokizono, Astushi Sato, Hiroyuki Tanaka, Atsushi Ogawa, Takako Fujita, Yoko Hiraki, Sachiko Kitanaka, Yoichi Matsubara, Toshio Makita, Masataka Taguri, Mitsuko Nakashima, Yoshinori Tsurusaki, Hirotomo Saitsu, Ko-ichiro Yoshiura, Naomichi Matsumoto, Norio Niikawa.   

Abstract

Kabuki syndrome is a congenital anomaly syndrome characterized by developmental delay, intellectual disability, specific facial features including long palpebral fissures and ectropion of the lateral third of the lower eyelids, prominent digit pads, and skeletal and visceral abnormalities. Mutations in MLL2 and KDM6A cause Kabuki syndrome. We screened 81 individuals with Kabuki syndrome for mutations in these genes by conventional methods (n = 58) and/or targeted resequencing (n = 45) or whole exome sequencing (n = 5). We identified a mutation in MLL2 or KDM6A in 50 (61.7%) and 5 (6.2%) cases, respectively. Thirty-five MLL2 mutations and two KDM6A mutations were novel. Non-protein truncating-type MLL2 mutations were mainly located around functional domains, while truncating-type mutations were scattered through the entire coding region. The facial features of patients in the MLL2 truncating-type mutation group were typical based on those of the 10 originally reported patients with Kabuki syndrome; those of the other groups were less typical. High arched eyebrows, short fifth finger, and hypotonia in infancy were more frequent in the MLL2 mutation group than in the KDM6A mutation group. Short stature and postnatal growth retardation were observed in all individuals with KDM6A mutations, but in only half of the group with MLL2 mutations.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  KDM6A; Kabuki syndrome; MLL2; genotype-phenotype correlation; mutation

Mesh:

Substances:

Year:  2013        PMID: 23913813     DOI: 10.1002/ajmg.a.36072

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  59 in total

1.  Alcohol exposure promotes DNA methyltransferase DNMT3A upregulation through reactive oxygen species-dependent mechanisms.

Authors:  Federico Miozzo; Hélène Arnould; Aurélie de Thonel; Anne-Laure Schang; Délara Sabéran-Djoneidi; Anne Baudry; Benoît Schneider; Valérie Mezger
Journal:  Cell Stress Chaperones       Date:  2017-07-15       Impact factor: 3.667

Review 2.  Examining the impact of gene variants on histone lysine methylation.

Authors:  Capucine Van Rechem; Johnathan R Whetstine
Journal:  Biochim Biophys Acta       Date:  2014-05-23

3.  Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.

Authors:  Hiroyuki Kato; Kaori Asamitsu; Wendi Sun; Shojiro Kitajima; Naoko Yoshizawa-Sugata; Takashi Okamoto; Hisao Masai; Lorenz Poellinger
Journal:  Oncogene       Date:  2020-02-18       Impact factor: 9.867

4.  Refractory ITP in a patient with Kabuki syndrome: response to low-dose rituximab.

Authors:  Brian Kerr; Philip Murphy; John Quinn
Journal:  Int J Hematol       Date:  2017-01-30       Impact factor: 2.490

Review 5.  Yin-yang actions of histone methylation regulatory complexes in the brain.

Authors:  Patricia Marie Garay; Margarete Aryanka Wallner; Shigeki Iwase
Journal:  Epigenomics       Date:  2016-11-18       Impact factor: 4.778

Review 6.  Enhancer biology and enhanceropathies.

Authors:  Edwin Smith; Ali Shilatifard
Journal:  Nat Struct Mol Biol       Date:  2014-03       Impact factor: 15.369

7.  The necessity for in vivo functional analysis in human medical genetics.

Authors:  Anita M Quintana
Journal:  Med Res Arch       Date:  2015-11

8.  Identification of Intellectual Disability Genes in Female Patients with a Skewed X-Inactivation Pattern.

Authors:  Nathalie Fieremans; Hilde Van Esch; Maureen Holvoet; Gert Van Goethem; Koenraad Devriendt; Monica Rosello; Sonia Mayo; Francisco Martinez; Shalini Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski; Joris R Vermeesch; Peter Marynen; Guy Froyen
Journal:  Hum Mutat       Date:  2016-05-25       Impact factor: 4.878

Review 9.  Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders.

Authors:  Christina N Vallianatos; Shigeki Iwase
Journal:  Epigenomics       Date:  2015       Impact factor: 4.778

10.  A comparative analysis of KMT2D missense variants in Kabuki syndrome, cancers and the general population.

Authors:  Víctor Faundes; Geraldine Malone; William G Newman; Siddharth Banka
Journal:  J Hum Genet       Date:  2018-11-20       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.